Orient Europharma Valuation

4120 Stock  TWD 41.05  0.55  1.36%   
At this time, the company appears to be overvalued. Orient Europharma holds a recent Real Value of NT$34.37 per share. The prevailing price of the company is NT$41.05. Our model determines the value of Orient Europharma from analyzing the company fundamentals such as Return On Equity of -0.0268, shares outstanding of 86.75 M, and Operating Margin of (0.01) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support buying undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
41.05
Please note that Orient Europharma's price fluctuation is very steady at this time. Calculation of the real value of Orient Europharma is based on 3 months time horizon. Increasing Orient Europharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Orient Europharma Co is useful when determining the fair value of the Orient stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Orient Europharma. Since Orient Europharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orient Stock. However, Orient Europharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  41.05 Real  34.37 Hype  41.05 Naive  38.68
The real value of Orient Stock, also known as its intrinsic value, is the underlying worth of Orient Europharma Company, which is reflected in its stock price. It is based on Orient Europharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Orient Europharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orient Europharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
34.37
Real Value
45.16
Upside
Estimating the potential upside or downside of Orient Europharma Co helps investors to forecast how Orient stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orient Europharma more accurately as focusing exclusively on Orient Europharma's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
39.5541.8144.06
Details
Hype
Prediction
LowEstimatedHigh
39.8341.0542.27
Details
Naive
Forecast
LowNext ValueHigh
37.4538.6839.90
Details

Orient Europharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Orient Europharma's current stock value. Our valuation model uses many indicators to compare Orient Europharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orient Europharma competition to find correlations between indicators driving Orient Europharma's intrinsic value. More Info.
Orient Europharma Co is rated below average in price to book category among related companies. It is rated fifth in price to sales category among related companies fabricating about  0.63  of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for Orient Europharma Co is roughly  1.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Orient Europharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Orient Europharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orient Europharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Orient Europharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Orient Europharma and how it compares across the competition.

About Orient Europharma Valuation

The stock valuation mechanism determines the current worth of Orient Europharma Co on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Orient Europharma Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Orient Europharma based exclusively on its fundamental and basic technical indicators. By analyzing Orient Europharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Orient Europharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orient Europharma. We calculate exposure to Orient Europharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Orient Europharma's related companies.

8 Steps to conduct Orient Europharma's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Orient Europharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Orient Europharma's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Orient Europharma's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Orient Europharma's revenue streams: Identify Orient Europharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Orient Europharma's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Orient Europharma's growth potential: Evaluate Orient Europharma's management, business model, and growth potential.
  • Determine Orient Europharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Orient Europharma's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Orient Europharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Orient Stock analysis

When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Please note, there is a significant difference between Orient Europharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orient Europharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orient Europharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.